News & Analysis as of

Biotechnology Public Private Partnerships (P3s)

Goodwin

Goodwin’s 2025 Rare Disease Symposium: Momentum Builds for Addressing Critical Diagnosis and Treatment Gaps

Goodwin on

Goodwin’s 2025 Rare Disease Symposium, held on February 5 in Boston and virtually, gathered patient advocates and caregivers, providers, researchers, biotech and medtech leaders, investors, and policy experts to discuss the...more

Goodwin

White House Announces “Bold Goals” for Biotech

Goodwin on

In a report entitled “Bold Goals for U.S. Biotechnology and Biomanufacturing,” the White House recently announced several biotech-related “bold goals” to advance the environmental, agricultural, economic, health, and science...more

Bergeson & Campbell, P.C.

ATP3 Workshop "Principles and Processes: Algae Culture Maintenance, Production and Downstream Processing" Approaching

The spring 2016 Algae Testbed Public-Private Partnership (ATP3) workshop entitled, "Principles and Processes: Algae Culture Maintenance, Production and Downstream Processing" is approaching. ...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide